全文获取类型
收费全文 | 93261篇 |
免费 | 42617篇 |
国内免费 | 247篇 |
专业分类
耳鼻咽喉 | 1969篇 |
儿科学 | 4545篇 |
妇产科学 | 906篇 |
基础医学 | 18271篇 |
口腔科学 | 5394篇 |
临床医学 | 13670篇 |
内科学 | 24386篇 |
皮肤病学 | 8221篇 |
神经病学 | 14446篇 |
特种医学 | 3516篇 |
外科学 | 17020篇 |
综合类 | 153篇 |
一般理论 | 24篇 |
预防医学 | 5008篇 |
眼科学 | 1819篇 |
药学 | 7062篇 |
中国医学 | 1228篇 |
肿瘤学 | 8487篇 |
出版年
2023年 | 103篇 |
2022年 | 103篇 |
2021年 | 1701篇 |
2020年 | 5315篇 |
2019年 | 11173篇 |
2018年 | 10553篇 |
2017年 | 11752篇 |
2016年 | 12496篇 |
2015年 | 12615篇 |
2014年 | 12720篇 |
2013年 | 13357篇 |
2012年 | 5943篇 |
2011年 | 5697篇 |
2010年 | 9790篇 |
2009年 | 5955篇 |
2008年 | 3180篇 |
2007年 | 1976篇 |
2006年 | 1920篇 |
2005年 | 1575篇 |
2004年 | 1363篇 |
2003年 | 1250篇 |
2002年 | 1238篇 |
2001年 | 960篇 |
2000年 | 753篇 |
1999年 | 346篇 |
1998年 | 145篇 |
1997年 | 111篇 |
1996年 | 103篇 |
1995年 | 91篇 |
1994年 | 78篇 |
1993年 | 69篇 |
1992年 | 158篇 |
1991年 | 156篇 |
1990年 | 134篇 |
1989年 | 106篇 |
1988年 | 114篇 |
1987年 | 135篇 |
1986年 | 109篇 |
1985年 | 106篇 |
1984年 | 76篇 |
1983年 | 82篇 |
1982年 | 42篇 |
1981年 | 37篇 |
1980年 | 29篇 |
1979年 | 51篇 |
1978年 | 64篇 |
1977年 | 28篇 |
1976年 | 29篇 |
1974年 | 29篇 |
1973年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Lance Rachel M. Natoli Michael J. Di Pumpo Fabio Beck Timothy P. Gatrell Alan Brown Gregory J. Schocken Derek Moon Richard E. 《Annals of biomedical engineering》2022,50(2):222-232
Annals of Biomedical Engineering - Divers who wish to prolong their time underwater while carrying less equipment often use devices called rebreathers, which recycle the gas expired after each... 相似文献
3.
4.
Ccile Toly‐Ndour Stphanie Huguet‐Jacquot Agns Mailloux Hlne Delaby Giorgia Canellini Martin L. Olsson Agneta Wikman Joke M. Koelewijn Jean‐Marc Minon Tobias J. Legler Frederik B. Clausen Mark Lambert Helen Ryan Irena Bricl Sys Hasslund Agnieszka Orzinska Katarzyna Guz Malgorzata Uhrynowska Antonella Matteocci Nuria Nogues Eduardo Muniz‐Diaz Susanna Sainio Masja De Haas C. Ellen Van der Schoot 《ISBT科学丛刊》2021,16(1):106-118
5.
6.
7.
8.
Sooyoung Kim Tae H. Park Woo I. Kim Suyeon Park Jae H. Kim Moon K. Cho 《Phytotherapy research : PTR》2021,35(1):374-383
Green tea extract (GTE) has been studied for the treatment of acne based on its anti‐inflammatory/antioxidant properties. This systematic review and meta‐analysis aimed to examine the effects of GTE on acne. Electronic databases, including PubMed, Embase, and the Cochrane Library were systematically searched up to August 2019. The effect size of acne lesion counts is presented as mean differences and 95% confidence intervals (CIs). Five randomized‐controlled studies were included in the meta‐analysis (N; experimental = 125, control = 122). GTE significantly reduced the number of inflammatory lesions (?9.38; 95% CI: ?14.13 to ?4.63). In subgroup analysis, topical GTE application significantly reduced the inflammatory lesion counts (?11.39; 95% CI: ?15.91 to ?6.86) whereas oral GTE intake showed minimal effect (?1.40; 95% CI: ?2.50 to ?0.30). Although GTE did not significantly reduce the number of non‐inflammatory lesions (?21.65; 95% CI: ?47.52 to 4.22), when stratified by the route of admission, non‐inflammatory acne lesions were significantly reduced by topical GTE application (?32.44; 95% CI: ?39.27 to ?25.62) but not with oral GTE administration (0.20; 95% CI: 0.00 to 0.40). This systematic review and meta‐analysis suggest that topical GTE application is beneficial for the treatment of acne without causing significant adverse events while oral GTE intake has limited effects. Further high‐quality clinical trials are warranted. 相似文献
9.
Sara García‐Oreja Francisco Javier lvaro‐Afonso Yolanda García‐lvarez Esther García‐Morales Irene Sanz‐Corbaln Jose Luis Lzaro Martínez 《Dermatologic therapy》2021,34(1):e14621
There are a wide variety of treatments for plantar warts, but none has been shown to be effective in all patients. We aimed to perform a systematic review of the efficacy of different topical treatments on plantar warts. Systematic electronic searches (Pubmed, Cochrane Library, Embase, and Web of Science) were conducted in April 2020. Meta‐analyses, systematic reviews, and retrospective or prospective clinical trials of the effects of topical and nonsurgical treatments of plantar warts were included. Two authors performed the study selection and data extraction. Any discrepancies between the two reviewers were discussed with a third reviewer. Forty‐four studies were included. The average cure rates of the most frequent treatments were variable across the studies: cryotherapy (45.61%), salicylic acid (13.6%), cantharidin‐podophyllin‐salicylic acid formulation (97.82%), laser (79.36%), topical antivirals (72.45%), intralesional bleomycin (83.37%), and intralesional immunotherapy (68.14%). Twenty‐two studies (50%) had a level of evidence 1b and grade of recommendation A, five studies (11.4%) had a level of evidence 2b and grade of recommendation B, two studies (4.5%) had a level of evidence 3b and grade of recommendation B, and 15 studies (34,1%) with a level of evidence 4 and grade of recommendation C. First‐choice treatments for common warts, such as cryotherapy and salicylic acid, have low‐cure rates for plantar warts. Other treatments, such as CPA formulation, immunotherapy, and intralesional bleomycin, which have compassionate use, have higher cure rates. This review should stimulate future high‐quality research to evaluate these specialized treatments. 相似文献
10.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献